跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
CELTAX INJECTION CONCENTRATE 40mg/ml with Diluent - HSA Drug Approval Details
Approvals
/
HSA
/
CELTAX INJECTION CONCENTRATE 40mg/ml with Diluent
Approved
THERAPEUTIC
CELTAX INJECTION CONCENTRATE 40mg/ml with Diluent
Mylan Laboratories Limited [OTL] (Drug product concentrate)Mylan Laboratories Limited [OTL] (Diluent)
🇸🇬 Health Sciences Authority
Approval Date
Dec 14, 2012
Approval ID
b4af281200e3659a
Company
Mylan Laboratories Limited [OTL] (Drug product concentrate)Mylan Laboratories Limited [OTL] (Diluent)
Type
Therapeutic
Approval Details
Approval Id
b4af281200e3659a
Drug Name
CELTAX INJECTION CONCENTRATE 40mg/ml with Diluent
Product Name
CELTAX INJECTION CONCENTRATE 40mg/ml with Diluent
Approval Number
SIN14276P
Approval Date
2012-12-14
Registrant
MYLAN PHARMACEUTICALS PTE. LTD.
Drug Type
Therapeutic
Forensic Classification
Prescription Only
Dosage Form
INJECTION, SOLUTION, CONCENTRATE
Route Of Administration
INTRAVENOUS
Atc Code
L01CD02
Atc Item Name
docetaxel
Pharma Manufacturer Name
mylan pharmaceuticals pte. ltd.
Active Ingredients
(Drug product concentrate) Docetaxel anhydrous
40mg/ml
(Drug product concentrate) Docetaxel anhydrous
40mg/ml
Approved
Quick Info
Agency
HSA
Country
🇸🇬
Approval Date
Dec 14, 2012
Approval ID
b4af281200e3659a
Type
Therapeutic
Back to HSA Approvals
